Editorial: Toxicity Mechanism and Clinical Features of PD-1/PD-L1 Inhibitors in Treatment of Cancer, Volume I

Detalles Bibliográficos
Autores principales: Kong, Xiangyi, Sullivan, Ryan J, Wu, Caisheng, Zhang, Lin, Jiang, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118018/
https://www.ncbi.nlm.nih.gov/pubmed/35600877
http://dx.doi.org/10.3389/fphar.2022.898368
_version_ 1784710431481266176
author Kong, Xiangyi
Sullivan, Ryan J
Wu, Caisheng
Zhang, Lin
Jiang, Yu
author_facet Kong, Xiangyi
Sullivan, Ryan J
Wu, Caisheng
Zhang, Lin
Jiang, Yu
author_sort Kong, Xiangyi
collection PubMed
description
format Online
Article
Text
id pubmed-9118018
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91180182022-05-20 Editorial: Toxicity Mechanism and Clinical Features of PD-1/PD-L1 Inhibitors in Treatment of Cancer, Volume I Kong, Xiangyi Sullivan, Ryan J Wu, Caisheng Zhang, Lin Jiang, Yu Front Pharmacol Pharmacology Frontiers Media S.A. 2022-05-05 /pmc/articles/PMC9118018/ /pubmed/35600877 http://dx.doi.org/10.3389/fphar.2022.898368 Text en Copyright © 2022 Kong, Sullivan, Wu, Zhang and Jiang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Kong, Xiangyi
Sullivan, Ryan J
Wu, Caisheng
Zhang, Lin
Jiang, Yu
Editorial: Toxicity Mechanism and Clinical Features of PD-1/PD-L1 Inhibitors in Treatment of Cancer, Volume I
title Editorial: Toxicity Mechanism and Clinical Features of PD-1/PD-L1 Inhibitors in Treatment of Cancer, Volume I
title_full Editorial: Toxicity Mechanism and Clinical Features of PD-1/PD-L1 Inhibitors in Treatment of Cancer, Volume I
title_fullStr Editorial: Toxicity Mechanism and Clinical Features of PD-1/PD-L1 Inhibitors in Treatment of Cancer, Volume I
title_full_unstemmed Editorial: Toxicity Mechanism and Clinical Features of PD-1/PD-L1 Inhibitors in Treatment of Cancer, Volume I
title_short Editorial: Toxicity Mechanism and Clinical Features of PD-1/PD-L1 Inhibitors in Treatment of Cancer, Volume I
title_sort editorial: toxicity mechanism and clinical features of pd-1/pd-l1 inhibitors in treatment of cancer, volume i
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118018/
https://www.ncbi.nlm.nih.gov/pubmed/35600877
http://dx.doi.org/10.3389/fphar.2022.898368
work_keys_str_mv AT kongxiangyi editorialtoxicitymechanismandclinicalfeaturesofpd1pdl1inhibitorsintreatmentofcancervolumei
AT sullivanryanj editorialtoxicitymechanismandclinicalfeaturesofpd1pdl1inhibitorsintreatmentofcancervolumei
AT wucaisheng editorialtoxicitymechanismandclinicalfeaturesofpd1pdl1inhibitorsintreatmentofcancervolumei
AT zhanglin editorialtoxicitymechanismandclinicalfeaturesofpd1pdl1inhibitorsintreatmentofcancervolumei
AT jiangyu editorialtoxicitymechanismandclinicalfeaturesofpd1pdl1inhibitorsintreatmentofcancervolumei

Ejemplares similares